{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:24:17Z","timestamp":1787221457768,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100015373","name":"American Society for the Prevention of Cruelty to Animals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Doxycycline and a macrocyclic lactone (ML\/doxy) are now standard additions to melarsomine treatment protocols. The safety and efficacy of the two-dose melarsomine protocol have not been revisited since these adjuncts were added to treatment guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective cohort study comparing two-dose and three-dose melarsomine in dogs with class 1 and 2 heartworm disease, treated at Miami-Dade Animal Services from 2014 to 2024. All dogs received ML\/doxy. Outcome measures were efficacy 5\u201310 months after the last melarsomine injection, survival to 8\u00a0weeks post-melarsomine, and post-treatment complications. Efficacy was assessed for different MLs administered at intake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Denominators for analyses varied on the basis of available data. There were 889 dogs in the two-dose melarsomine group and 357 in the three-dose group. Follow-up antigen tests were negative in 242\/252 dogs (96.0%; confidence interval [CI] 92.9\u201397.8%) in the two-dose group and 24\/24 (100%; CI 86.2\u2013100%) in the three-dose group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.9999; not significant [NS]). All-cause mortality was 4\/491 (0.8%) in the two-dose group and 4\/154 (2.6%) in the three-dose group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.097; NS). Heartworm-related mortality was 1\/491 (0.2%) in the two-dose group and remained at 4\/154 (2.6%) in the three-dose group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.013). The deaths in the three-dose group were not considered to be related to the specific treatment protocol. Mild post-melarsomine complications occurred in 66\/889 (7.4%) dogs in the two-dose group and 13\/357 (3.6%) in the three-dose group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.014). Severe complications occurred in 3\/889 (0.3%) dogs in the two-dose group and 5\/357 (1.4%) in the three-dose group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.047). Two dogs that initially received ivermectin (2\/65; 3.1%) and two that received milbemycin (2\/35; 5\/7%) had a positive follow-up antigen test, compared with none (0\/33) for sustained-release moxidectin.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings suggest that two-dose melarsomine, with ML\/doxy, is a potential alternative to three-dose melarsomine for class 1 and 2 heartworm disease. Moxidectin may be the preferred ML in the two-dose protocol.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-026-07344-x","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:29:10Z","timestamp":1787218150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A retrospective comparison of two-dose and three-dose melarsomine, with doxycycline and a macrocyclic lactone, in 1246 shelter dogs"],"prefix":"10.1186","volume":"19","author":[{"given":"Linda S.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"DiGangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia K.","family":"Cuccinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah M.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"7344_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.vetpar.2008.09.008","volume":"158","author":"JW McCall","year":"2008","unstructured":"McCall JW, Genchi C, Kramer L, Guerrero J, Dzimianski MT, Supakorndej P, et\u00a0al. Heartworm and Wolbachia: therapeutic implications. Vet Parasitol. 2008;158:204\u201314. https:\/\/doi.org\/10.1016\/j.vetpar.2008.09.008.","journal-title":"Vet Parasitol"},{"key":"7344_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1109\/iemc.2005.1559183","volume-title":"Canine guidelines for the prevention, diagnosis, and management of heartworm (Dirofilaria immitis) infection in dogs","author":"C Nelson","year":"2024","unstructured":"Nelson C, McCall J, Moorhead A, Starkey L, Ames M. Canine guidelines for the prevention, diagnosis, and management of heartworm (Dirofilaria immitis) infection in dogs. American Heartworm Society; 2024. p. 1\u201344. https:\/\/doi.org\/10.1109\/iemc.2005.1559183."},{"key":"7344_CR3","unstructured":"Association of Shelter Veterinarians position statement: heartworm management in animal shelters; 2019. p. 1\u20138. https:\/\/asv.memberclicks.net\/assets\/docs\/ASV.Heartworm_Management.pdf."},{"key":"7344_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.vetpar.2014.03.023","volume":"206","author":"KC Polak","year":"2014","unstructured":"Polak KC, Smith-Blackmore M. Animal shelters: managing heartworms in resource-scarce environments. Vet Parasitol. 2014;206:78\u201382. https:\/\/doi.org\/10.1016\/j.vetpar.2014.03.023.","journal-title":"Vet Parasitol"},{"key":"7344_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13071-024-06153-4","volume":"17","author":"MB Still","year":"2024","unstructured":"Still MB, Tedesco D, Hawkins C, Putnam H. Improving access to melarsomine therapy: treating canine heartworm infection in a high-volume, outpatient community clinic setting. Parasit Vectors. 2024;17:119. https:\/\/doi.org\/10.1186\/s13071-024-06153-4.","journal-title":"Parasit Vectors"},{"key":"7344_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2020.109130","volume":"282","author":"BA DiGangi","year":"2020","unstructured":"DiGangi BA. The American Heartworm Society and Association of Shelter Veterinarians\u2019 2019 shelter heartworm management practices survey. Vet Parasitol. 2020;282:109130. https:\/\/doi.org\/10.1016\/j.vetpar.2020.109130.","journal-title":"Vet Parasitol"},{"key":"7344_CR7","doi-asserted-by":"crossref","unstructured":"Daugherty L, Schuch C. Access to Veterinary Care: Barriers and Insights from Pet Families. 2025. Available from: https:\/\/trace.tennessee.edu\/utk_socipubs\/39\/. Accessed 21 Dec 2025.","DOI":"10.7290\/r1n7sh"},{"key":"7344_CR8","unstructured":"Gallup, PetSmart Charities. State of pet care study: pet parents\u2019 assessment of American Veterinary Care. https:\/\/www.gallup.com\/file\/analytics\/659183\/PetSmart%20Charities-Gallup-State%20of%20Pet%20Care-Report.pdf. Accessed 25 Jan 2026."},{"key":"7344_CR9","unstructured":"Boehringer Ingelheim Animal Health. Immiticide (melarsomine dihydrochloride) 2019. https:\/\/docs.boehringer-ingelheim.com\/IMMITICIDE%20Detailer.pdf."},{"key":"7344_CR10","unstructured":"Zoetis. Diroban; 2020. https:\/\/www.zoetisus.com\/products\/dogs\/diroban\/resources\/diroban-prescribing-information.pdf."},{"key":"7344_CR11","doi-asserted-by":"publisher","DOI":"10.56771\/asvguidelines.2022","author":"L DeTar","year":"2022","unstructured":"DeTar L, Doyle E, O\u2019Quin J, Aziz C, Berliner E, Bradley-Siemens N, et\u00a0al. The guidelines for standards of care in animal shelters. Second Edition. J Shelter Med Community Anim Health. 2022. https:\/\/doi.org\/10.56771\/asvguidelines.2022.","journal-title":"J Shelter Med Community Anim Health"},{"key":"7344_CR12","unstructured":"Vezzoni A, Genchi C, Raynaud JP. Adulticide efficacy of RM 340 in dogs with mild and severe natural infections. In: Soll MD (ed). Proceedings of the Heartworm Symposium \u201892, Austin, Texas. American Heartworm Society; 1992. p. 231\u201340."},{"key":"7344_CR13","unstructured":"Keister M, Dzimianski M, McTier T, McCall J, Brown J. Dose selection and confirmation of RM 340, a new filaricide for the treatment of dogs with immature and mature Dirofilaria immitis. In: Soll MD (ed). Proceedings of the heartworm symposium \u201892, Austin, Texas. American Heartworm Society, 1992. p. 225\u20139."},{"key":"7344_CR14","unstructured":"Case JL, Tanner PA, Keister DM, Meo NJ. A clinical field trial of melarsomine dihydrochloride (RM340) in dogs with severe (Class 3) heartworm disease. In: Soll M, Knight DH (eds). Proceedings of the heartworm symposium \u201895, Auburn, Alabama. American Heartworm Society 1995. p. 243\u201350."},{"key":"7344_CR15","unstructured":"Dzimianski M, McCall J, McTier T, Keister D, Strickland J. Preliminary results of the efficacy of RM 340 administered seasonally to heartworm antigen- and microfilaria-positive dogs living outdoors in a heartworm endemic area. In: Soll MD (ed). Proceedings of the heartworm symposium \u201892, Austin, Texas. American Heartworm Society; 1992. p. 241\u201347."},{"key":"7344_CR16","unstructured":"Miller M, Keister D, Tanner P, Meo N. Clinical efficacy of melarsomine dihydrochloride (RM340) and thiacetarsamide in dogs with moderate (Class 2) heartworm disease. In: Soll M, Knight DH (eds). Proceedings of the heartworm symposium \u201895, Auburn, Alabama. American Heartworm Society; 1995. p. 233\u201341."},{"key":"7344_CR17","unstructured":"Keister M, Tanner P, Meo. NJ. Immiticide(R): review of discovery, development, and utility. In: Soll M, Knight DH (eds). Proceedings of the heartworm symposium \u201895, Auburn, Alabama. American Heartworm Society; 1995. p. 201\u201319."},{"key":"7344_CR18","unstructured":"Di Sacco B, Vezzoni A. Clinical classification of heartworm disease for the purpose of adding objectivity to the assessment of therapeutic efficacy of adulticidal drugs in the field. In: Soll MD (ed). Proceedings of the heartworm symposium \u201892, Austin, Texas. American Heartworm Society; 1992. p. 209\u201314."},{"key":"7344_CR19","unstructured":"Dzimianski MT, McTier TL, McCall JW, Raynaud J-P. Assessment of filaricidal activity of a new filaricide (RM 340) against immature and adult heartworms using experimental canine models. In: Otto G (ed). Proceedings of the heartworm symposium \u201989, Washington, DC. American Heartworm Society; 1989. p. 147\u201353."},{"key":"7344_CR20","unstructured":"Atwell R, Searle C. The adulticide efficacy and safety of RM340 in a field trial. In: Soll MD (ed).Proceedings of the heartworm symposium \u201892, Austin, Texas. American Heartworm Society; 1992. p. 249\u201351."},{"key":"7344_CR21","unstructured":"Atwell RB, Searle ACE. Therapeutic efficacy of RM340 in pound dogs infected with Dirofilaria immitis. In: Otto G (ed). Proceedings of the heartworm symposium \u201989, Washington, DC. American Heartworm Society; 1989. p. 143\u20135."},{"key":"7344_CR22","unstructured":"Freeman JR, Keister, MD, Gonzalez, CM. Postmarketing pharmacovigilance of adverse reactions associated with the use of Immiticide. In: Seward, RL, Knight, DH (eds). Recent advances in heartworm disease: symposium '98. American Heartworm Society; 1989. p. 229\u201333."},{"key":"7344_CR23","unstructured":"Rubin SB, Nelson CT, Carithers D, Graham W, Buzhardt LF, Jones S, et al. Diagnosis, prevention and management of heartworm (Dirofilaria immitis) infection in dogs. American Heartworm Society, Wilmington, DE; 2010. http:\/\/www.heartwormsociety.org\/veterinary-resources\/guidelines-Can-HW-Disease.pdf."},{"key":"7344_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.vetpar.2005.07.008","volume":"133","author":"CT Nelson","year":"2005","unstructured":"Nelson CT, McCall JW, Rubin SB, Buzhardt L, Doiron D, Graham W, et\u00a0al. 2005 guidelines for the diagnosis, prevention and management of heartworm (Dirofilaria immitis) infection in dogs. Vet Parasitol. 2005;133:255\u201366.","journal-title":"Vet Parasitol"},{"key":"7344_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.vetpar.2011.01.021.18","volume":"176","author":"L Kramer","year":"2011","unstructured":"Kramer L, Grandi G, Passeri B, Gianelli P, Genchi M, Dzimianski MT, et\u00a0al. Evaluation of lung pathology in Dirofilaria immitis-experimentally infected dogs treated with doxycycline or a combination of doxycycline and ivermectin before administration of melarsomine dihydrochloride. Vet Parasitol. 2011;176:357\u201360. https:\/\/doi.org\/10.1016\/j.vetpar.2011.01.021.18.","journal-title":"Vet Parasitol"},{"key":"7344_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.vetpar.2011.01.022","volume":"176","author":"JW McCall","year":"2011","unstructured":"McCall JW, Kramer L, Genchi C, Guerrero J, Dzimianski MT, Supakorndej P, et\u00a0al. Effects of doxycycline on early infections of Dirofilaria immitis in dogs. Vet Parasitol. 2011;176:361\u20137. https:\/\/doi.org\/10.1016\/j.vetpar.2011.01.022.","journal-title":"Vet Parasitol"},{"key":"7344_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/J.VETPAR.2008.09.014","volume":"158","author":"L Kramer","year":"2008","unstructured":"Kramer L, Grandi G, Leoni M, Passeri B, McCall J, Genchi C, et\u00a0al. Wolbachia and its influence on the pathology and immunology of Dirofilaria immitis infection. Vet Parasitol. 2008;158:191\u20135. https:\/\/doi.org\/10.1016\/J.VETPAR.2008.09.014.","journal-title":"Vet Parasitol"},{"key":"7344_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-025-06720-3","volume":"18","author":"Y Chu","year":"2025","unstructured":"Chu Y, Sakamoto K, Evans CC, Dzimianski MT, Fricks C, Mansour A, et\u00a0al. Real-time PCR and immunohistochemistry detection of Wolbachia in adult Dirofilaria immitis from dogs treated with doxycycline and ivermectin. Parasit Vectors. 2025;18:1\u201310. https:\/\/doi.org\/10.1186\/s13071-025-06720-3.","journal-title":"Parasit Vectors"},{"key":"7344_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.vetpar.2018.03.005","volume":"254","author":"L Kramer","year":"2018","unstructured":"Kramer L, Crosara S, Gnudi G, Genchi M, Mangia C, Viglietti A, et\u00a0al. Wolbachia, doxycycline and macrocyclic lactones: new prospects in the treatment of canine heartworm disease. Vet Parasitol. 2018;254:95\u20137. https:\/\/doi.org\/10.1016\/j.vetpar.2018.03.005.","journal-title":"Vet Parasitol"},{"key":"7344_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.vetpar.2010.07.019","volume":"174","author":"MID Rossi","year":"2010","unstructured":"Rossi MID, Paiva J, Bendas A, Mendes-de-Almeida F, Knackfuss F, Miranda M, et\u00a0al. Effects of doxycycline on the endosymbiont Wolbachia in Dirofilaria immitis (Leidy, 1856)-naturally infected dogs. Vet Parasitol. 2010;174:119\u201323. https:\/\/doi.org\/10.1016\/j.vetpar.2010.07.019.","journal-title":"Vet Parasitol"},{"key":"7344_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.vetpar.2014.09.023","volume":"206","author":"JW McCall","year":"2014","unstructured":"McCall JW, Kramer L, Genchi C, Guerrero J, Dzimianski MT, Mansour A, et\u00a0al. Effects of doxycycline on heartworm embryogenesis, transmission, circulating microfilaria, and adult worms in microfilaremic dogs. Vet Parasitol. 2014;206:5\u201313. https:\/\/doi.org\/10.1016\/j.vetpar.2014.09.023.","journal-title":"Vet Parasitol"},{"key":"7344_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-017-2446-4","volume":"10","author":"CT Nelson","year":"2017","unstructured":"Nelson CT, Myrick ES, Nelson TA. Clinical benefits of incorporating doxycycline into a canine heartworm treatment protocol. Parasit Vectors. 2017;10:1\u20134. https:\/\/doi.org\/10.1186\/s13071-017-2446-4.","journal-title":"Parasit Vectors"},{"key":"7344_CR33","unstructured":"Soll MD, Knight DH, Courtney CH, King RK, Lok JB. Recommended procedures for the diagnosis, prevention, and management of heartworm (Dirofilaria immitis) infection in dogs. In: Soll M, Knight DH (eds). Proceedings of the heartworm symposium \u201895, Auburn, Alabama. American Heartworm Society; 1995. p. 303\u20138."},{"key":"7344_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13071-017-2433-9","volume":"10","author":"DD Bowman","year":"2017","unstructured":"Bowman DD, Drake J. Examination of the \u201csusceptibility gap\u201d in the treatment of canine heartworm infection. Parasit Vectors. 2017;10:65\u201373.","journal-title":"Parasit Vectors"},{"key":"7344_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1053\/j.tcam.2011.07.001","volume":"26","author":"DD Bowman","year":"2011","unstructured":"Bowman DD, Mannella C. Macrocyclic lactones and Dirofilaria immitis microfilariae. Top Companion Anim Med. 2011;26:160\u201372.","journal-title":"Top Companion Anim Med"},{"key":"7344_CR36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.vetpar.2014.09.011","volume":"206","author":"JW McCall","year":"2014","unstructured":"McCall JW, Arther R, Davis W, Settje T. Safety and efficacy of 10% imidacloprid + 2.5% moxidectin for the treatment of Dirofilaria immitis circulating microfilariae in experimentally infected dogs. Vet Parasitol. 2014;206:86\u201392.","journal-title":"Vet Parasitol"},{"key":"7344_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.vetpar.2010.01.025","volume":"169","author":"G Grandi","year":"2010","unstructured":"Grandi G, Quintavalla C, Mavropoulou A, Genchi M, Gnudi G, Bertoni G, et\u00a0al. A combination of doxycycline and ivermectin is adulticidal in dogs with naturally acquired heartworm disease (Dirofilaria immitis). Vet Parasitol. 2010;169:347\u201351.","journal-title":"Vet Parasitol"},{"key":"7344_CR38","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.ijpara.2008.03.002","volume":"38","author":"C Bazzocchi","year":"2008","unstructured":"Bazzocchi C, Mortarino M, Grandi G, Kramer LH, Genchi C, Bandi C, et\u00a0al. Combined ivermectin and doxycycline treatment has microfilaricidal and adulticidal activity against Dirofilaria immitis in experimentally infected dogs. Int J Parasitol. 2008;38:1401\u201310.","journal-title":"Int J Parasitol"},{"key":"7344_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.vetpar.2014.06.014","volume":"205","author":"A Mavropoulou","year":"2014","unstructured":"Mavropoulou A, Gnudi G, Grandi G, Volta A, Kramer LH, Quintavalla C. Clinical assessment of post-adulticide complications in Dirofilaria immitis-naturally infected dogs treated with doxycycline and ivermectin. Vet Parasitol. 2014;205:211\u20135.","journal-title":"Vet Parasitol"},{"key":"7344_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-023-05769-2","volume":"16","author":"JW McCall","year":"2023","unstructured":"McCall JW, Mansour A, DiCosty U, Fricks C, McCall S, Dzimianski MT, et\u00a0al. Long-term evaluation of viability of microfilariae and intravenously transplanted adult Dirofilaria immitis in microfilaremic dogs treated with low-dose, short- and long-treatment regimens of doxycycline and ivermectin. Parasit Vectors. 2023;16:1\u20138. https:\/\/doi.org\/10.1186\/s13071-023-05769-2.","journal-title":"Parasit Vectors"},{"key":"7344_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-023-05704-5","volume":"16","author":"JW McCall","year":"2023","unstructured":"McCall JW, DiCosty U, Mansour A, Fricks C, McCall S, Dzimianski MT, et\u00a0al. Inability of Dirofilaria immitis infective larvae from mosquitoes fed on blood from microfilaremic dogs during low-dose and short-treatment regimens of doxycycline and ivermectin to complete normal development in heartworm na\u00efve dogs. Parasit Vectors. 2023;16:1\u20137. https:\/\/doi.org\/10.1186\/s13071-023-05704-5.","journal-title":"Parasit Vectors"},{"key":"7344_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.vetpar.2014.08.011","volume":"206","author":"R Chandrashekar","year":"2014","unstructured":"Chandrashekar R, Beall MJ, Saucier J, O\u2019Connor T, McCall JW, McCall SD. Experimental Dirofilaria immitis infection in dogs: effects of doxycycline and Advantage Multi\u00ae administration on immature adult parasites. Vet Parasitol. 2014;206:93\u20138.","journal-title":"Vet Parasitol"},{"key":"7344_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2021.702018","author":"LS Jacobson","year":"2021","unstructured":"Jacobson LS, DiGangi BA. An accessible alternative to melarsomine: \u201cmoxi-doxy\u201d for treatment of adult heartworm infection in dogs. Front Vet Sci. 2021;8:702018. https:\/\/doi.org\/10.3389\/fvets.2021.702018.","journal-title":"Front Vet Sci"},{"key":"7344_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-022-05625-9","volume":"16","author":"KA Ward","year":"2023","unstructured":"Ward KA, Jacobson LS, Lacaden AB, Harrison KA. Further variation of the adulticide protocol for the treatment of canine heartworm infection: can it be even shorter and cost less? Parasit Vectors. 2023;16:144. https:\/\/doi.org\/10.1186\/s13071-022-05625-9.","journal-title":"Parasit Vectors"},{"key":"7344_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2020.109194","volume":"284","author":"T Paterson","year":"2020","unstructured":"Paterson T, Fernandez C, Burnett PJ, Lessey L, Hockley T, Hagen R, et\u00a0al. Heartworm control in Grenada, West Indies: results of a field study using imidacloprid 10% + moxidectin 2.5% and doxycycline for naturally-acquired Dirofilaria immitis infections. Vet Parasitol. 2020;284:109194. https:\/\/doi.org\/10.1016\/j.vetpar.2020.109194.","journal-title":"Vet Parasitol"},{"key":"7344_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2020.109156","volume":"283","author":"I Maerz","year":"2020","unstructured":"Maerz I. Clinical and diagnostic imaging findings in 37 rescued dogs with heartworm disease in Germany. Vet Parasitol. 2020;283:109156. https:\/\/doi.org\/10.1016\/j.vetpar.2020.109156.","journal-title":"Vet Parasitol"},{"key":"7344_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.vetpar.2014.05.033","volume":"206","author":"E Maxwell","year":"2014","unstructured":"Maxwell E, Ryan K, Reynolds C, Pariaut R. Outcome of a heartworm treatment protocol in dogs presenting to Louisiana State University from 2008 to 2011: 50 cases. Vet Parasitol. 2014;206:71\u20137.","journal-title":"Vet Parasitol"},{"key":"7344_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.vetpar.2015.02.036","volume":"209","author":"JC M\u00e9ndez","year":"2015","unstructured":"M\u00e9ndez JC, Carret\u00f3n E, Mart\u00ednez-Subiela S, Tvarijonaviciute A, Cer\u00f3n JJ, Montoya-Alonso JA. Acute phase protein response in heartworm-infected dogs after adulticide treatment. Vet Parasitol. 2015;209:197\u2013201.","journal-title":"Vet Parasitol"},{"key":"7344_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/vr.146.16.466","author":"ZS Polizopoulou","year":"2000","unstructured":"Polizopoulou ZS, Koutinas AF, Saridomichelakis MN, Patsikas MN, Leontidis LS, Roubies NA, et al. Clinical and laboratory observations in 91 dogs infected with Dirofilaria immitis in northern Greece. Vet Rec. 2000;146:466\u20139. https:\/\/doi.org\/10.1136\/vr.146.16.466.","journal-title":"Vet Rec"},{"key":"7344_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/jsap.13677","volume":"65","author":"G Romito","year":"2024","unstructured":"Romito G, Pane E, Guglielmini C, Poser H, Valente C, Paradies P, et\u00a0al. Efficacy and tolerability of the American Heartworm Society therapeutic protocol in dogs affected by heartworm disease without caval syndrome. J Small Anim Pract. 2024;65:39\u201346.","journal-title":"J Small Anim Pract"},{"key":"7344_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-018-3264-z","volume":"11","author":"MD Savadelis","year":"2018","unstructured":"Savadelis MD, Day KM, Bradner JL, Wolstenholme AJ, Dzimianski MT, Moorhead AR. Efficacy and side effects of doxycycline versus minocycline in the three-dose melarsomine canine adulticidal heartworm treatment protocol. Parasite Vectors. 2018;11:1\u20137. https:\/\/doi.org\/10.1186\/s13071-018-3264-z.","journal-title":"Parasite Vectors"},{"key":"7344_CR52","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/vbz.2021.0108","volume":"22","author":"K V\u00f6r\u00f6s","year":"2022","unstructured":"V\u00f6r\u00f6s K, Becker Z, K\u00f3nya R, Arany-T\u00f3th A, Farkas R. Application of moxidectin and ultrasound-aided injection of melarsomine during the American Heartworm Society recommended treatment protocol in Dirofilaria immitis infected dogs. Vector Borne Zoonotic Dis. 2022;22:382\u201390.","journal-title":"Vector Borne Zoonotic Dis"},{"key":"7344_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-017-2427-7","author":"WK Yoon","year":"2017","unstructured":"Yoon WK, Kim YW, Suh SIL, Choi R, Lee SG, Hyun C. Evaluation of cardiopulmonary and inflammatory markers in dogs with heartworm infection during treatment with the 2014 American Heartworm Society recommended treatment protocol. Parasit Vectors. 2017;10:535. https:\/\/doi.org\/10.1186\/s13071-017-2427-7.","journal-title":"Parasit Vectors"},{"key":"7344_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17555\/jvc.2017.02.34.1.1","volume":"34","author":"M Choi","year":"2017","unstructured":"Choi M, Yoon WK, Suh SI, Hyun C. Assessment of clinical outcome in dogs with naturally infected with Dirofilaria immitis after American Heartworm Society protocol vs slow kill method. J Vet Clin. 2017;34:1\u20136. https:\/\/doi.org\/10.17555\/jvc.2017.02.34.1.1.","journal-title":"J Vet Clin"},{"key":"7344_CR55","doi-asserted-by":"crossref","unstructured":"Pulmonary thromboembolism and hypertension after thiacetarsamide vs melarsomine dihydrochloride treatment of Dirofilaria immitis infection in dogs. Am J Vet Res. 1993;54:920-5.","DOI":"10.2460\/ajvr.1993.54.06.920"},{"key":"7344_CR56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.vetpar.2019.06.006","volume":"271","author":"E Carret\u00f3n","year":"2019","unstructured":"Carret\u00f3n E, Falc\u00f3n-Cord\u00f3n Y, Falc\u00f3n-Cord\u00f3n S, Morch\u00f3n R, Matos JI, Montoya-Alonso JA. Variation of the adulticide protocol for the treatment of canine heartworm infection: can it be shorter? Vet Parasitol. 2019;271:54\u20136. https:\/\/doi.org\/10.1016\/j.vetpar.2019.06.006.","journal-title":"Vet Parasitol"},{"key":"7344_CR57","unstructured":"Atwell R, Tarish JH. The effect of oral, low-dose prednisolone on the extent of pulmonary pathology associated with dead Dirofilaria immitis in a canine lung model. In: Soll MD, Knight D, editors. Proceedings of the heartworm symposium \u201895. Auburn, Alabama. American Heartworm Society; 1995. p. 103\u201311."},{"key":"7344_CR58","unstructured":"Nelson CT, McCall JW, Jones S, Moorhead A. Current canine guidelines for the prevention, diagnosis, and management of heartworm (Dirofilaria immitis) infection in dogs. American Heartworm Society, Wilmington, DE; 2018 https:\/\/www.heartwormsociety.org\/images\/pdf\/2018-AHS-Canine-Guidelines.pdf."},{"key":"7344_CR59","unstructured":"Costa Rodr\u00edguez N, Morchon Garc\u00eda R, Morales Fuente BR, Vera Rodr\u00edguez DJ, Montoya Alonso JA, et\u00a0al. Use of corticosteroids during adulticide treatment in dogs with heartworm: is it a risk or a benefit? Proceedings of 8th ESDA days and the 2025 annual EVPC scientific meeting, Thessaloniki, Greece; 2025. p. 50\u20131. https:\/\/accedacris.ulpgc.es\/jspui\/handle\/10553\/139380"},{"key":"7344_CR60","unstructured":"Companion Animal Parasite Council (CAPC). Parasite Prevalence Maps for Miami-Dade County (2025). https:\/\/www.petsandparasites.org\/parasite-prevalence-maps\/?utm_source=chatgpt.com#\/2025\/all-year\/heartworm-canine\/dog\/united-states\/florida\/363-miami-dade-county. Accessed 24 Jan 2026"},{"key":"7344_CR61","doi-asserted-by":"publisher","unstructured":"Gruntmeir JM, Long MT, Blagburn BL, Walden HS. Canine heartworm and heat treatment: An evaluation using a well based enzyme-linked immunosorbent assay (ELISA) and canine sera with confirmed heartworm infection status. Vet Parasitol. 2020;283:109169. Accessed 24 Jan 2026. https:\/\/doi.org\/10.1016\/j.vetpar.2020.109169","DOI":"10.1016\/j.vetpar.2020.109169"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07344-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-026-07344-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07344-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:29:32Z","timestamp":1787218172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13071-026-07344-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7344"],"URL":"https:\/\/doi.org\/10.1186\/s13071-026-07344-x","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involved retrospective analysis of existing veterinary medical records. No animals were examined for the purpose of this study, and no identifiable human data were included. Ethical approval was not required.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"359"}}